Consilient Health is proud to announce the launch of Methylphenidate 2mg/ml Oral Solution

Consilient Health is proud to announce the introduction of the only licensed liquid formulation of methylphenidate hydrochloride immediate release in the UK.

This latest addition to our portfolio underscores our commitment to diversifying treatment options and enhancing the patient experience.

Recognizing the varied needs of young patients, this launch aligns with our dedication to meeting the evolving needs in healthcare, continually seeking to improve patient choice and accessibility.